The global AnimalModelServices market size is predicted to grow from US$ 3525 million in 2025 to US$ 5368 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Animal model services involve the use of live animals in scientific research to simulate human biological processes and disease conditions. These services are crucial in preclinical studies for testing the efficacy and safety of new drugs, therapies, and medical devices before proceeding to human trials. They provide researchers with valuable insights into disease mechanisms, drug interactions, and treatment outcomes, ensuring a controlled and ethical approach to advancing medical science.

Market Driver

The animal model services market is primarily driven by the rising demand for preclinical studies in drug discovery and development. With the increasing prevalence of chronic diseases and the need for innovative treatments, pharmaceutical and biotechnology companies rely heavily on animal models to evaluate the efficacy and safety of new therapies. Additionally, advancements in genetic engineering have enabled the creation of more precise animal models that mimic human disease conditions, further fueling market growth.

Market Challenge

A significant challenge in the animal model services market is the growing ethical concerns and regulatory restrictions surrounding animal testing. Public awareness and advocacy for animal welfare have led to stricter guidelines, making it imperative for researchers and companies to justify and minimize the use of animal models. Furthermore, the high cost of maintaining facilities and acquiring genetically modified animals poses financial challenges, particularly for smaller research organizations.

Market Trend

An emerging trend in the animal model services market is the adoption of alternative and complementary methods to reduce reliance on animal testing. Technologies like organ-on-a-chip, 3D cell cultures, and computer-based simulations are being integrated into research workflows to provide more ethical and cost-effective solutions. Additionally, the development of humanized animal models, which more accurately replicate human biological systems, is gaining traction, aligning with the demand for translational and precision medicine research.

LPI (LP Information) newest research report, the AnimalModelServices Industry Forecast looks at past sales and reviews total world AnimalModelServices sales in 2024, providing a comprehensive analysis by region and market sector of projected AnimalModelServices sales for 2025 through 2031. With AnimalModelServices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AnimalModelServices industry.

This Insight Report provides a comprehensive analysis of the global AnimalModelServices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AnimalModelServices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global AnimalModelServices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AnimalModelServices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AnimalModelServices.

This report presents a comprehensive overview, market shares, and growth opportunities of AnimalModelServices market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Rats
    Mice
    Others

Segmentation by Application:

    Academic & Research Institutes
    Pharmaceutical & Biotechnology Companies

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Charles River Laboratories
    Envigo
    Taconic Biosciences
    Jackson Laboratory
    Crown Biosciences
    Shanghai SLAC
    Shangghai Modelorg
    GenOway
    Syngene International
    Psychogenics
    Pharmaron
    Pharmalegacy
    Vitalstar Biotechnology
    JANVIER LABS